You have no items in your shopping cart.
Description
Research Area
Immunology & Inflammation
Images & Validation
−
| Tested Applications | IHC |
|---|---|
| Dilution Range | IHC: 1/50-1/200; ELISA: 1/5000-1/10000 |
| Reactivity | Human |
Key Properties
−| Antibody Type | Primary Antibody |
|---|---|
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | Rabbit IgG |
| Immunogen | Synthetic peptide of human CD52 |
| Target | FDA approved drug target related |
| Conjugation | Unconjugated |
Storage & Handling
−| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
|---|---|
| Buffer/Preservatives | Purified antibody in PBS with 0.05% sodium azide and 50% glycerol. |
| Concentration | Approximately 1mg/ml (varies from batch to batch). Please inquire for precise concentration. |
| Expiration Date | 12 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−HE5, CDW52, EDDM5
Similar Products
−Anti-CD52 [Alemtuzumab (Campath-1H)] [orb1152527]
ELISA, FC, IHC-Fr, IHC-P, WB
Human, Primate
Human
Monoclonal
Unconjugated
0.2 mgAnti-CD52 [Alemtuzumab (Campath-1H)] [orb348863]
ELISA, FC, IHC-Fr, IHC-P, WB
Human, Primate
Human
Monoclonal
Unconjugated
0.2 mgHuman Cluster of Differentiation 52 (CD52) ELISA Kit [orb778879]
Human
0.79-50 ng/mL
0.31 ng/mL
48 T, 96 TCD52 Antibody [orb1672259]
Cytotoxic Assay, ELISA, FC, IHC-Fr, IHC-P, In vivo, WB
Human, Primate
Recombinant
Unconjugated
0.2 mgAnti-CD52 [YTH 34.5-G2b (Campath-1G)] [orb348851]
ELISA, FC, IHC-Fr, IHC-P, WB
Human, Primate
Rat
Monoclonal
Unconjugated
0.2 mg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb1152527_1.png)
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb1152527_2.png)
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb1152527_3.png)
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb1152527_4.png)
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb1152527_5.png)
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb1152527_6.png)
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb1152527_7.png)
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb1152527_8.png)
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb348863_1.png)
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb348863_2.png)
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb348863_3.png)
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb348863_4.png)
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb348863_5.png)
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb348863_6.png)







![Anti-CD52 [YTH 34.5-G2b (Campath-1G)]](/images/pub/media/catalog/product/NewWebsite/35/orb348851_1.png)
![Anti-CD52 [YTH 34.5-G2b (Campath-1G)]](/images/pub/media/catalog/product/NewWebsite/35/orb348851_2.png)